In response to critical unmet needs in oligonucleotide delivery, Corden Pharma provides value-added solutions for delivering these therapeutic actives using a unique combination of products and services.
The following readily available products can be used in liposomal and other lipid-based delivery systems which are designed for oligonucleotide-based delivery:
Synthetic phospholipids |
Sphingolipids |
Cationic lipids |
“Helper” lipids |
Through an integrated resource of custom manufacturing experience and expertise, Corden Pharma’s core competencies in lipids, peptides, polymers, carbohydrates, lipo-peptides, and other small molecules provide proprietary, high quality, GMP excipients needed for cutting-edge oligonucleotide-based delivery systems.
Additional advantages to custom manufacturing through Corden Pharma are optimized synthesis routes, development of scalable processes, efficient transition into cGMP production from pre-clinical to commercial scale, and step-wise implementation of analytical and regulatory support required for filing